Page last updated: 2024-10-16

adenine and Bone Diseases

adenine has been researched along with Bone Diseases in 15 studies

Bone Diseases: Diseases of BONES.

Research Excerpts

ExcerptRelevanceReference
" Further, the addition of single-dose TDF to single-dose nevirapine (SD-NVP) during delivery following maternal ZDV use during pregnancy significantly reduces the frequency of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance."8.85Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: is it time to move on from zidovudine? ( Foster, C; Gibb, DM; Lyall, H; Olmscheid, B; Pearce, G; Zhang, S, 2009)
"Hypogonadism was first described in the setting of advanced AIDS and can be primary or secondary."6.47Endocrine complications of human immunodeficiency virus infection: hypogonadism, bone disease and tenofovir-related toxicity. ( Cotter, AG; Powderly, WG, 2011)
" Further, the addition of single-dose TDF to single-dose nevirapine (SD-NVP) during delivery following maternal ZDV use during pregnancy significantly reduces the frequency of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance."4.85Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: is it time to move on from zidovudine? ( Foster, C; Gibb, DM; Lyall, H; Olmscheid, B; Pearce, G; Zhang, S, 2009)
" Here, we established a rat model with secondary hyperparathyroidism (SHPT) and bone disease induced by adenine and a high phosphorous diet and analyzed the skeletal characteristics."3.88A rat model of SHPT with bone abnormalities in CKD induced by adenine and a high phosphorus diet. ( Chen, Q; Liu, BC; Lv, LL; Ni, HF; Ni, LH; Song, KY; Tang, RN; Wang, B; Wang, FM; Wang, LT; Wu, M, 2018)
"Hypogonadism was first described in the setting of advanced AIDS and can be primary or secondary."2.47Endocrine complications of human immunodeficiency virus infection: hypogonadism, bone disease and tenofovir-related toxicity. ( Cotter, AG; Powderly, WG, 2011)
" The granule form carries a risk of dosing errors and has a particularly strong, unpleasant taste."1.40Tenofovir in HIV-infected children. Antiretroviral efficacy, but beware of adverse effects on bone and the kidneys. ( , 2014)

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (20.00)29.6817
2010's11 (73.33)24.3611
2020's1 (6.67)2.80

Authors

AuthorsStudies
Sato, H3
Goto, M3
Nishimura, G3
Morimoto, N3
Tokushima, H3
Horii, Y3
Takahashi, N3
Diwan, V1
Brown, L1
Gobe, GC1
Ni, LH1
Tang, RN1
Lv, LL1
Wu, M1
Wang, B1
Wang, FM1
Ni, HF1
Song, KY1
Wang, LT1
Chen, Q1
Liu, BC1
Ichchou, L1
Rist, S1
Lespessailles, E1
PriƩ, D1
Benhamou, CL1
Puthanakit, T1
Siberry, GK1
Mangioni, D1
Bandera, A1
Muscatello, A1
Squillace, N1
Crivellaro, C1
Guerra, L1
Messa, C1
Gori, A1
Lockhart, SM1
Drevets, DA1
Maggi, P1
Montinaro, V1
Leone, A1
Fasano, M1
Volpe, A1
Bellacosa, C1
Grattagliano, V1
Coladonato, L1
Lapadula, G1
Santantonio, T1
Angarano, G1
Gervasoni, C1
Minisci, D1
Meraviglia, P1
Baldelli, S1
Clementi, E1
Rizzardini, G1
Cattaneo, D1
Foster, C1
Lyall, H1
Olmscheid, B1
Pearce, G1
Zhang, S1
Gibb, DM1
Carr, A1
Hoy, J1
Cotter, AG1
Powderly, WG1
Brim, NM1
Cu-Uvin, S1
Hu, SL1
O'Bell, JW1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Maternal and Infant Monitoring for Evidence of Toxicity Related to Tenofovir Exposure: The Bone and Kidney Health Substudy of the IMPAACT 1077 PROMISE Protocol (Promoting Maternal and Infant Survival Everywhere)[NCT01066858]1,765 participants (Actual)Observational2011-03-22Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

4 reviews available for adenine and Bone Diseases

ArticleYear
Adenine-induced chronic kidney disease in rats.
    Nephrology (Carlton, Vic.), 2018, Volume: 23, Issue:1

    Topics: Adenine; Animals; Bone Diseases; Cardiovascular Diseases; Disease Models, Animal; Disease Progressio

2018
Bone health in children and adolescents with perinatal HIV infection.
    Journal of the International AIDS Society, 2013, Jun-18, Volume: 16

    Topics: Adenine; Adolescent; Anti-HIV Agents; Bone Density; Bone Diseases; Child; HIV Infections; Humans; Or

2013
Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: is it time to move on from zidovudine?
    HIV medicine, 2009, Volume: 10, Issue:7

    Topics: Adenine; Adult; Africa South of the Sahara; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly

2009
Endocrine complications of human immunodeficiency virus infection: hypogonadism, bone disease and tenofovir-related toxicity.
    Best practice & research. Clinical endocrinology & metabolism, 2011, Volume: 25, Issue:3

    Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bone Diseases; Endocrine System Dis

2011

Other Studies

11 other studies available for adenine and Bone Diseases

ArticleYear
Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
    Bone, 2023, Volume: 167

    Topics: Adenine; Animals; Bone Diseases; Calcium; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid H

2023
Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
    Bone, 2023, Volume: 167

    Topics: Adenine; Animals; Bone Diseases; Calcium; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid H

2023
Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
    Bone, 2023, Volume: 167

    Topics: Adenine; Animals; Bone Diseases; Calcium; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid H

2023
Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
    Bone, 2023, Volume: 167

    Topics: Adenine; Animals; Bone Diseases; Calcium; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid H

2023
Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
    Bone, 2023, Volume: 167

    Topics: Adenine; Animals; Bone Diseases; Calcium; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid H

2023
Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
    Bone, 2023, Volume: 167

    Topics: Adenine; Animals; Bone Diseases; Calcium; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid H

2023
Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
    Bone, 2023, Volume: 167

    Topics: Adenine; Animals; Bone Diseases; Calcium; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid H

2023
Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
    Bone, 2023, Volume: 167

    Topics: Adenine; Animals; Bone Diseases; Calcium; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid H

2023
Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
    Bone, 2023, Volume: 167

    Topics: Adenine; Animals; Bone Diseases; Calcium; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid H

2023
A rat model of SHPT with bone abnormalities in CKD induced by adenine and a high phosphorus diet.
    Biochemical and biophysical research communications, 2018, 04-06, Volume: 498, Issue:3

    Topics: Adenine; Animals; Bone and Bones; Bone Density; Bone Diseases; Bone Diseases, Metabolic; Diet; Disea

2018
Reversible increase in FGF23 in a hypophosphatemic renal and bone disease linked to antiviral therapy by adefovir.
    Joint bone spine, 2013, Volume: 80, Issue:6

    Topics: Adenine; Aged; Antiviral Agents; Bone Diseases; Female; Fibroblast Growth Factor-23; Fibroblast Grow

2013
Focal bone lesions in HIV-positive patient treated with tenofovir.
    BMC infectious diseases, 2014, Mar-06, Volume: 14

    Topics: Adenine; Anti-HIV Agents; Bone Diseases; HIV Infections; Humans; Male; Middle Aged; Organophosphonat

2014
Reversible bone lesions induced by tenofovir disoproxil fumarate.
    AIDS (London, England), 2014, Jan-28, Volume: 28, Issue:3

    Topics: Adenine; Adult; Bone Diseases; Female; Humans; Organophosphonates; Radionuclide Imaging; Tenofovir

2014
Tenofovir in HIV-infected children. Antiretroviral efficacy, but beware of adverse effects on bone and the kidneys.
    Prescrire international, 2014, Volume: 23, Issue:149

    Topics: Adenine; Anti-HIV Agents; Bone Diseases; Child; Dose-Response Relationship, Drug; HIV Infections; Hu

2014
Bone and kidney toxicity induced by nucleotide analogues in patients affected by HBV-related chronic hepatitis: a longitudinal study.
    The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:4

    Topics: Adenine; Adult; Aged; Antiviral Agents; Bone Diseases; Drug-Related Side Effects and Adverse Reactio

2015
Determinants of bone diseases in tenofovir-treated HIV patients.
    AIDS (London, England), 2016, 06-19, Volume: 30, Issue:10

    Topics: Adenine; Anti-HIV Agents; Bone Diseases; HIV Infections; Humans; Tenofovir

2016
Tenofovir: new indication. In chronic hepatitis B: beware bone toxicity.
    Prescrire international, 2009, Volume: 18, Issue:101

    Topics: Adenine; Antiviral Agents; Bone and Bones; Bone Diseases; Double-Blind Method; Drug Approval; Europe

2009
Low bone mineral density with tenofovir: does statistically significant mean clinically significant?
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Oct-15, Volume: 51, Issue:8

    Topics: Adenine; Adult; Anti-HIV Agents; Bone Density; Bone Diseases; Female; Fractures, Bone; HIV Infection

2010
Bone disease and pathologic fractures in a patient with tenofovir-induced Fanconi syndrome.
    The AIDS reader, 2007, Volume: 17, Issue:6

    Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bone Diseases; Fanconi Syndrome; Fe

2007